Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Sanderling Ventures VII Fund, 9/2013 $30M

Offices

San Mateo, USA
400 S. El Camino Real
Suite 1200
San Mateo, CA, 94402
USA

People

Founder & Managing Director
Founder
operating partner
Operating Partner
Managing Director
Managing Director
Managing Director & Head - San Diego Office
Chief Financial Officer & Principa
General Counsel & Principal

Tags

Sanderling Ventures

Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling demonstrates that significant companies are best built in close working partnerships with entrepreneurs.Sanderling’s unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both its entrepreneurs and investors. Biomedical investing has been a viable sector in the technology markets for more than thirty years, and in the past ten years has experienced accelerated growth. Since its inception, Sanderling has supported over 60 biomedical companies from very early stages through commercial development, earning consistently high rates-of-return on its venture investments.

Recent Milestones

Investments

Company Date Round Size Participants
Lineagen 12/2013Series C$3.5M8
ViaCyte 7/2013Series C$10.6M2
Torax Medical 9/2012Series D$30M5
TheraVida 4/2012Venture Round$1M1
Sotera Wireless 12/2011Series D$12.2M4
Lineagen 11/2011Series B$16M4
Chimerix 2/2011Series F$45M8
InfraReDx 10/2010Series D$21M1
Lineagen 8/2010Series A$10.8M4
Gemin X Pharmaceuticals 8/2010Series E$8M2
TheraVida 7/2010Debt$3.6M1
Sotera Wireless 4/2010Series C$10.8M4
Gemin X Pharmaceuticals 4/2010Series D$16M2
Neomend 1/2010Series D$30M5
Endocyte 1/2010Series C$26M5
CalciMedica 12/2009Series C$12M3
Trinity Biosystems 11/2009Debt$7.5M5
Chimerix 8/2009Series E$16.1M4
Axikin Pharmaceuticals 1/2009Series A$3M2
CalciMedica 1/2009Series C$4M3
Gemin X Pharmaceuticals 7/2008Series C$38M13
Actimis Pharmaceuticals 6/2008Venture Round$9.6M1
Asteres 6/2008Venture Round$4M1
Sotera Wireless 3/2008Series B$20.3M4
CalciMedica 2/2008Series B$5.5M2
Taligen Therapeutics 1/2008Series B$65M4
Asteres 11/2007Series C$4M3
ViaCyte 7/2007Series C$25M4
Chimerix 2/2007Series D$23.1M4
Trinity Biosystems 7/2006Series B$21M4
ViaCyte 5/2006Venture Round$20M8
Xytis 1/2006Series B$24.5M4
Taligen Therapeutics 8/2005Series A$3.75M3
Torax Medical 6/2005Series B$10M3
Actimis Pharmaceuticals 4/2005Series A$6M2
Asteres 11/2004Series B2
Chimerix 11/2004Series C$11M3
Artielle ImmunoTherapeutics 6/2004Series A4
Asteres 9/2003Series A1

Videos

Sources

  1. BDC and Fonds de solidarité commit to Sanderling Ventures VII (canadianprivateequity.com) [edit]
  2. Lineagen Raises Financings (finsmes.com) [edit]
  3. ViaCyte Raises $10.6 Mln (pehub.com) [edit]
  4. Torax Medical Completes $30M Series D Financing (finsmes.com) [edit]
  5. VC Funding: Q2 2012 source [edit]
  6. Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement With Cerner (prnewswire.com) [edit]
  7. Lineagen to Complete $15M Series B Equity Funding Round (finsmes.com) [edit]
  8. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 (chimerix-inc.com) [edit]
  9. Heart device firm InfraReDX lands $21M financing (masshightech.com) [edit]
  10. Lineagen, Inc. Closes $5 Million to Complete $10.8 Million Series A Round (businesswire.com) [edit]
  11. Gemin X Pharmaceuticals, Inc.: Series E $8M (onbiovc.com) [edit]
  12. TheraVida raises $3.6M to develop drug platform (venturebeat.com) [edit]
  13. Sotera Wireless Raises $10.75 Million (pehub.com) [edit]
  14. Gemin X books $16M Series D as it pursues PhIIb cancer trial Read more: http://www.fiercebiotech.com/story/gemin-x-books-16m-series-d-it-pursues-phiib-cancer-trial/2010-04-20#ixzz0lfnwA8xR (fiercebiotech.com) [edit]
  15. Neomend Closes $30M Funding Round (finsmes.com) [edit]
  16. Endocyte, Inc.: Series C $26M (onbiovc.com) [edit]
  17. CalciMedica Closes Second Tranche of $12M Series C Financing (finsmes.com) [edit]
  18. SEC D/A (sec.gov) [edit]
  19. VC insiders inject $16M into Chimerix (fiercebiotech.com) [edit]
  20. Axikin Pharmaceuticals Spins out of Actimis (reuters.com) [edit]
  21. CalciMedica, Inc.: Series C $4M (onbiovc.com) [edit]
  22. Gemin X Pharmaceuticals closes $38 Mn Series C financing (siliconindia.com) [edit]
  23. Capital Funding Report [edit]
  24. Asteres, Inc. Obtains $4,000,000 New Funding (xconomy.com) [edit]
  25. SOTERA WIRELESS RAISES $20.3 MILLION IN SERIES B FINANCING ROUND LED BY QUALCOMM VENTURES (soterawireless.com) [edit]
  26. SEC (sec.gov) [edit]
  27. Taligen Therapeutics Secures Series B Financing (taligentherapeutics.com) [edit]
  28. Asteres Receives $4 Million Additional Financing (venturedeal.com) [edit]
  29. Novocell Raises $25 Million (novocell.com) [edit]
  30. Chimerix Raises $23.1 Million to Advance Antiviral Drug Pipeline (prnewswire.com) [edit]
  31. EDGAR [edit]
  32. EDGAR [edit]
  33. Xytis Inc. Raises $24.5 Million in Series B Financing (xytis.com) [edit]
  34. Taligen Therapeutics Announces Successful Achievement of Series A Milestone (taligentherapeutics.com) [edit]
  35. Torax Medical lands $10M in financing (bizjournals.com) [edit]
  36. ACTIMIS PHARMACEUTICALS, COMPLETES $6 MILLION SERIES A FINANCING (actimis.com) [edit]
  37. Asteres Inc. Completes Series B Financing (businesswire.com) [edit]
  38. Chimerix Raises $11 Million (chimerix-inc.com) [edit]
  39. Citation Needed [add]
  40. Asteres Inc. Completes Series A Financing (businesswire.com) [edit]
Edit This Page
Last Edited 3/29/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy